Islam Zaki

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 31

Top Venues

Molecules (Basel, Switzerland)

RSC advances

Future medicinal chemistry

ACS omega

Port Said University Faculty of Pharmacy

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Port Said University Faculty of Pharmacy

Egypt

Assistant Professor :: Organic Chemistry Department

Publications

Dalal Nasser Binjawhar, Fawziah A Al-Salmi, Maha Ali Alghamdi, Arwa Sultan Alqahtani, Eman Fayad, Rasha Mohammed Saleem, Islam Zaki, Amal Mahmoud Youssef Moustafa
Design, Synthesis, and Biological Evaluation of Newly Synthesized Cinnamide-Fluorinated Containing Compounds as Bioactive Anticancer Agents. ACS omega 9 (16) (2024)
Noha Ryad, Ayman Abo Elmaaty, Ibrahim M Ibrahim, Ali Hassan Ahmed Maghrabi, Maryam Abdulrahman Yahya Alahdal, Rasha Mohammed Saleem, Islam Zaki, Lina M A Abdel Ghany
Harnessing molecular hybridization approach to discover novel quinoline EGFR-TK inhibitors for cancer treatment. Future medicinal chemistry 16 (11) (2024)
Hany M Abd El-Lateef, Duaa Bafail, Noura Hamdi Yousef Alhalees, Eslam E M Toson, Ali H Abu Almaaty, Elsherbiny H Elsayed, Islam Zaki, Magdy M Youssef
Synthesis, characterization and biological research of novel 2-(quinoline-4-carbonyl)hydrazide-acrylamide hybrids as potential anticancer agents on MCF-7 breast carcinoma cells by targeting EGFR-TK. RSC advances 14 (32) (2024)
Dalal Nasser Binjawhar, Fawziah A Al-Salmi, Maha Ali Alghamdi, Arwa Sultan Alqahtani, Eman Fayad, Rasha Mohammed Saleem, Islam Zaki, Amal Mahmoud Youssef Moustafa
Design, Synthesis, and Biological Evaluation of Newly Synthesized Cinnamide-Fluorinated Containing Compounds as Bioactive Anticancer Agents. ACS omega 9 (16) (2024)
Noha Ryad, Ayman Abo Elmaaty, Ibrahim M Ibrahim, Ali Hassan Ahmed Maghrabi, Maryam Abdulrahman Yahya Alahdal, Rasha Mohammed Saleem, Islam Zaki, Lina M A Abdel Ghany
Harnessing molecular hybridization approach to discover novel quinoline EGFR-TK inhibitors for cancer treatment. Future medicinal chemistry (2024)
Dalal Nasser Binjawhar, Fawziah A Al-Salmi, Ola A Abu Ali, Maha Ali Alghamdi, Eman Fayad, Rasha Mohammed Saleem, Islam Zaki, N A Farouk
Design, synthesis and cytotoxic activity of molecular hybrids based on quinolin-8-yloxy and cinnamide hybrids and their apoptosis inducing property. RSC advances 14 (16) (2024)
Dalal Nasser Binjawhar, Fawziah A Al-Salmi, Ola A Abu Ali, Maha Ali Alghamdi, Eman Fayad, Rasha Mohammed Saleem, Islam Zaki, N A Farouk
Design, synthesis and cytotoxic activity of molecular hybrids based on quinolin-8-yloxy and cinnamide hybrids and their apoptosis inducing property. RSC advances 14 (16) (2024)
Noha Ryad, Ayman Abo Elmaaty, Ibrahim M Ibrahim, Ali Hassan Ahmed Maghrabi, Maryam Abdulrahman Yahya Alahdal, Rasha Mohammed Saleem, Islam Zaki, Lina M A Abdel Ghany
Harnessing molecular hybridization approach to discover novel quinoline EGFR-TK inhibitors for cancer treatment. Future medicinal chemistry 16 (11) (2024)
Noha Ryad, Ayman Abo Elmaaty, Ibrahim M Ibrahim, Ali Hassan Ahmed Maghrabi, Maryam Abdulrahman Yahya Alahdal, Rasha Mohammed Saleem, Islam Zaki, Lina M A Abdel Ghany
Harnessing molecular hybridization approach to discover novel quinoline EGFR-TK inhibitors for cancer treatment. Future medicinal chemistry 16 (11) (2024)
Noha Ryad, Ayman Abo Elmaaty, Ibrahim M Ibrahim, Ali Hassan Ahmed Maghrabi, Maryam Abdulrahman Yahya Alahdal, Rasha Mohammed Saleem, Islam Zaki, Lina M A Abdel Ghany
Harnessing molecular hybridization approach to discover novel quinoline EGFR-TK inhibitors for cancer treatment. Future medicinal chemistry 16 (11) (2024)
Hany M Abd El-Lateef, Duaa Bafail, Noura Hamdi Yousef Alhalees, Eslam E M Toson, Ali H Abu Almaaty, Elsherbiny H Elsayed, Islam Zaki, Magdy M Youssef
Synthesis, characterization and biological research of novel 2-(quinoline-4-carbonyl)hydrazide-acrylamide hybrids as potential anticancer agents on MCF-7 breast carcinoma cells by targeting EGFR-TK. RSC advances 14 (32) (2024)
Hany M Abd El-Lateef, Mohammed A I Elbastawesy, Tamer Mohamed Abdelghani Ibrahim, Mai M Khalaf, Mohamed Gouda, Mariam G F Wahba, Islam Zaki, Martha M Morcoss
Design, Synthesis, Docking Study, and Antiproliferative Evaluation of Novel Schiff Base-Benzimidazole Hybrids with VEGFR-2 Inhibitory Activity. Molecules (Basel, Switzerland) 28 (2) (2023)
Hany M Abd El-Lateef, Mohammed A I Elbastawesy, Tamer Mohamed Abdelghani Ibrahim, Mai M Khalaf, Mohamed Gouda, Mariam G F Wahba, Islam Zaki, Martha M Morcoss
Design, Synthesis, Docking Study, and Antiproliferative Evaluation of Novel Schiff Base-Benzimidazole Hybrids with VEGFR-2 Inhibitory Activity. Molecules (Basel, Switzerland) 28 (2) (2023)
Eman Fayad, Sarah Awwadh Altalhi, Matokah M Abualnaja, Abdulmohsen H Alrohaimi, Fahmy G Elsaid, Ali H Abu Almaaty, Rasha Mohammed Saleem, Mohammed A Bazuhair, Ali Hassan Ahmed Maghrabi, Botros Y Beshay, Islam Zaki
Novel Acrylate-Based Derivatives: Design, Synthesis, Antiproliferative Screening, and Docking Study as Potential Combretastatin Analogues. ACS omega 8 (41) (2023)
Hany M Abd El-Lateef, Mohammed A I Elbastawesy, Tamer Mohamed Abdelghani Ibrahim, Mai M Khalaf, Mohamed Gouda, Mariam G F Wahba, Islam Zaki, Martha M Morcoss
Design, Synthesis, Docking Study, and Antiproliferative Evaluation of Novel Schiff Base-Benzimidazole Hybrids with VEGFR-2 Inhibitory Activity. Molecules (Basel, Switzerland) 28 (2) (2023)
Hany M Abd El-Lateef, Ayman Abo Elmaaty, Lina M A Abdel Ghany, Mohamed S Abdel-Aziz, Islam Zaki, Noha Ryad
Design and Synthesis of 2-(4-Bromophenyl)Quinoline-4-Carbohydrazide Derivatives via Molecular Hybridization as Novel Microbial DNA-Gyrase Inhibitors. ACS omega 8 (20) (2023)
Hany M Abd El-Lateef, Mohammed A I Elbastawesy, Tamer Mohamed Abdelghani Ibrahim, Mai M Khalaf, Mohamed Gouda, Mariam G F Wahba, Islam Zaki, Martha M Morcoss
Design, Synthesis, Docking Study, and Antiproliferative Evaluation of Novel Schiff Base-Benzimidazole Hybrids with VEGFR-2 Inhibitory Activity. Molecules (Basel, Switzerland) 28 (2) (2023)
Dalal Sulaiman Alshaya, Rana M O Tawakul, Islam Zaki, Ali H Abu Almaaty, Eman Fayad, Yasmin M Abd El-Aziz
Design, synthesis and antiproliferative screening of newly synthesized acrylate derivatives as potential anticancer agents. RSC advances 13 (34) (2023)
Hany M Abd El-Lateef, Lina M A Abdel Ghany, Rasha Mohammed Saleem, Ali Hassan Ahmed Maghrabi, Maryam Abdulrahman Yahya Alahdal, Eman Hussain Khalifa Ali, Botros Y Beshay, Islam Zaki, Reham E Masoud
Design, synthesis and antiproliferative screening of newly synthesized coumarin-acrylamide hybrids as potential cytotoxic and apoptosis inducing agents. RSC advances 13 (46) (2023)
Tarfah Al-Warhi, Adil Aldhahrani, Fayez Althobaiti, Eman Fayad, Ola A Abu Ali, Sarah M Albogami, Ali Hussein Abu Almaaty, Amgad I M Khedr, Syed Nasir Abbas Bukhari, Islam Zaki
Design, Synthesis and Cytotoxic Activity Evaluation of Newly Synthesized Amides-Based TMP Moiety as Potential Anticancer Agents over HepG2 Cells. Molecules (Basel, Switzerland) 27 (12) (2022)
Hend M A Maaroof, Bander Albogami, Reham A I Abou-Elkhair, Abdalla E A Hassan, Fatma I Al-Akhrasy, Salem A A El-Massry, Eman Fayad, Hamzah H Ahmed, Islam Zaki
Design, Synthesis, Characterization, and Molluscicidal Activity Screening of New Nicotinonitrile Derivatives against Land Snails, M. cartusiana . Molecules (Basel, Switzerland) 27 (23) (2022)
Hend M A Maaroof, Bander Albogami, Reham A I Abou-Elkhair, Abdalla E A Hassan, Fatma I Al-Akhrasy, Salem A A El-Massry, Eman Fayad, Hamzah H Ahmed, Islam Zaki
Design, Synthesis, Characterization, and Molluscicidal Activity Screening of New Nicotinonitrile Derivatives against Land Snails, M. cartusiana . Molecules (Basel, Switzerland) 27 (23) (2022)
Hend M A Maaroof, Bander Albogami, Reham A I Abou-Elkhair, Abdalla E A Hassan, Fatma I Al-Akhrasy, Salem A A El-Massry, Eman Fayad, Hamzah H Ahmed, Islam Zaki
Design, Synthesis, Characterization, and Molluscicidal Activity Screening of New Nicotinonitrile Derivatives against Land Snails, M. cartusiana . Molecules (Basel, Switzerland) 27 (23) (2022)
Hend M A Maaroof, Bander Albogami, Reham A I Abou-Elkhair, Abdalla E A Hassan, Fatma I Al-Akhrasy, Salem A A El-Massry, Eman Fayad, Hamzah H Ahmed, Islam Zaki
Design, Synthesis, Characterization, and Molluscicidal Activity Screening of New Nicotinonitrile Derivatives against Land Snails, M. cartusiana . Molecules (Basel, Switzerland) 27 (23) (2022)
Tarfah Al-Warhi, Matokah Abualnaja, Ola A Abu Ali, Fayez Althobaiti, Fahad Alharthi, Fahmy Gad Elsaid, Ali A Shati, Eman Fayad, Doaa Elghareeb, Ali Hussein Abu Almaaty, Islam Zaki
Synthesis and Biological Activity Screening of Newly Synthesized Trimethoxyphenyl-Based Analogues as Potential Anticancer Agents. Molecules (Basel, Switzerland) 27 (14) (2022)
Syed Nasir Abbas Bukhari, Hasan Ejaz, Mervat A Elsherif, Kashaf Junaid, Islam Zaki, Reham E Masoud
Design and Synthesis of Some New Furan-Based Derivatives and Evaluation of In Vitro Cytotoxic Activity. Molecules (Basel, Switzerland) 27 (8) (2022)
Syed Nasir Abbas Bukhari, Mohamed Y Zakaria, Muhammad Usman Munir, Naveed Ahmad, Mervat A Elsherif, Rasha Emad Badr, Ahmad Khalaf Hassan, Ali Hussein Abu Almaaty, Islam Zaki
Design, Synthesis, In Vitro Biological Activity Evaluation and Stabilized Nanostructured Lipid Carrier Formulation of Newly Synthesized Schiff Bases-Based TMP Moieties. Pharmaceuticals (Basel, Switzerland) 15 (6) (2022)
Islam Zaki, Sara A Abu El-Ata, Eman Fayad, Ola A Abu Ali, Ali Hussein Abu Almaaty, Ahmed S Saad
Evaluation of Synthetic 2,4-Disubstituted-benzo[g]quinoxaline Derivatives as Potential Anticancer Agents. Pharmaceuticals (Basel, Switzerland) 14 (9) (2021)
Islam Zaki, Reham A I Abou-Elkhair, Ali Hussein Abu Almaaty, Ola A Abu Ali, Eman Fayad, Ahmed Gaafar Ahmed Gaafar, Mohamed Y Zakaria
Design and Synthesis of Newly Synthesized Acrylamide Derivatives as Potential Chemotherapeutic Agents against MCF-7 Breast Cancer Cell Line Lodged on PEGylated Bilosomal Nano-Vesicles for Improving Cytotoxic Activity. Pharmaceuticals (Basel, Switzerland) 14 (10) (2021)
Ali Hussein Abu Almaaty, Eslam E M Toson, El-Sherbiny H El-Sayed, Mohamed A M Tantawy, Eman Fayad, Ola A Abu Ali, Islam Zaki
5-Aryl-1-Arylideneamino-1H-Imidazole-2(3H)-Thiones: Synthesis and In Vitro Anticancer Evaluation. Molecules (Basel, Switzerland) 26 (6) (2021)
Islam Zaki, Heba M M Ramadan, El-Sherbiny H El-Sayed, Mohamed Abd El-Moneim
Design, synthesis, and cytotoxicity screening of new synthesized imidazolidine-2-thiones as VEGFR-2 enzyme inhibitors. Archiv der Pharmazie 353 (11) (2020)

Islam Zaki.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Islam Zaki